ReactWise, a startup from Cambridge, U.K., is harnessing artificial intelligence to significantly accelerate the drug manufacturing process. By optimizing chemical processes, the AI-driven platform claims to speed up traditional methods by up to 30 times. Co-founder Alexander Pomberger explained that their software simplifies the development of drug recipes by consolidating five years of academic research into an accessible tool. The company is currently running 12 pilot trials with pharmaceutical firms and has raised $3.4 million in pre-seed funding, aiming to enhance efficiency in bringing new drugs to market.